Alzheon Secures New Financing

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    394 Lowell St Lexington, MA 02420
  • Company Description
    Alzheon is a clinical-stage biotechnology company focused on brain health, memory and aging, developing innovative treatments for Alzheimer’s disease and other neurodegenerative disorders. We are building a pipeline of innovative drugs to target the underlying pathogenesis of neurodegeneration in order to alter the course of progression in these debilitating diseases.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor

By posting a comment, you agree to our terms and conditions.